Sun Pharmaceutical Industries Limited has informed the Exchange about Approval of Composite Scheme of Arrangement by NCLT
SUNPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sun Pharmaceutical Industries has received approval from the National Company Law Tribunal (NCLT) for its Composite Scheme of Arrangement. The specific details of the scheme — such as which entities or businesses are involved, the structure, or any share swap ratio — are not disclosed in this filing. This approval is a significant regulatory milestone that moves the scheme closer to becoming effective. Once the scheme is fully implemented, it could lead to restructuring of the company's business or subsidiaries.
Shareholders should watch for follow-up filings that disclose the scheme's details, effective date, and any impact on shareholding or capital structure. In the short term, the news is largely procedural and may not materially move the stock unless the scheme involves a major acquisition, demerger, or capital change.